CDER Opens Docket for Comment on Quality Management Maturity Program

CDER is seeking comments on the development of its Quality Management Maturity (QMM) program, establishing a public docket to collect input from stakeholders who manufacture human drugs, including biologics.
Source: Drug Industry Daily